Abstract

Approximately one-fifth of the NA-treated CHB patients with advanced liver fibrosis and compensated cirrhosis experienced progression of liver fibrosis after PEG-IFN α-2a treatment. The GPR at 24 weeks of treatment was an independent predictive factor for the progression of liver fibrosis in this population.

Affiliated Institutions

Related Publications

Publication Info

Year
2025
Type
article
Citations
0
Access
Closed

External Links

Citation Metrics

0
OpenAlex

Cite This

Ling Li, Huili Li, Yiru Zhao et al. (2025). The ratio of GGT to PLT indices is a predictive factor for the progression of liver fibrosis in NA-treated chronic hepatitis B patients with advanced fibrosis plus PEG-IFN α-2a therapy: a case–control study. BMC Gastroenterology . https://doi.org/10.1186/s12876-025-04508-4

Identifiers

DOI
10.1186/s12876-025-04508-4